Calvert Research Licenses New Technologies
Calvert Research develops young technologies
In these challenging economic times, those with early-stage drug technologies may have difficulty obtaining adequate funding to proceed. Often young technologies are too early-stage to attract the interest of pharmaceutical companies. We at Calvert Laboratories understand you have a passion for your program and want to see your lead compound get the chance to progress to the clinic.
Calvert Research, a separate company from Calvert Laboratories, may be able to help. Calvert Research in-licenses early stage drug technologies, manages these projects internally by tenured pharmaceutical industry professionals and has the funding to progress these programs to the clinic. Calvert Research has contacts in pharma with whom they work to ensure that each program is optimally developed and tailored for a successful licensing at the clinical stage.
For more information, visit the Calvert Research website, and to determine whether your program might qualify for the in-licensing program, please contact Andy Burch.




